# SUPERNUS PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-05T15:31:21.915751+00:00 | | Last reviewed | 2026-10-05T15:31:21.915751+00:00 | ## Identity - Legal name: SUPERNUS PHARMACEUTICALS, INC. - Display name: SUPERNUS PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce | | As of | 2026-10-05T21:15:03.187106+00:00 | | Completeness | 0.364 | | Record Quality | 0.83 | | Directors | 8 | | Committees | 0 | | Governance events | 8 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Bethany L. Sensenig: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:6 - Carrolee Barlow: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:7 - Frederick M. Hudson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2010-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:9 - Georges Gemayel: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:10 - Jack A. Khattar: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2005-01-01. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:12 - Carrolee Barlow, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:8 - Charles W. Newhall, III: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:5 - Georges Gemayel, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:11 ## Executive leadership - Jonathan Rubin: Senior Vice President, Chief Medical Officer, Research and Development. Status: current. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:15 - Prat S. Bhatt: Senior Vice President of Intellectual Property, Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:18 - William Todd Horich: Senior Vice President, Commercial Operations, Marketing, and Market Access. Status: current. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:20 - Frank Mottola: Senior Vice President, Chief Technical Operations Officer. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:13 - Jack A. Khattar: President, Chief Executive Officer and Secretary [CEO]. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:14 - Jonathan Rubin, M.D.: Senior Vice President, Chief Medical Officer, Research and Development. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:16 - Padmanabh P. Bhatt, Ph.D.: Senior Vice President of Intellectual Property, Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:17 - Timothy C. Dec: Senior Vice President, Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:19 - William Todd Horich, Ph.D., MBA: Senior Vice President, Commercial Operations, Marketing, and Market Access. Status: unknown. claim_id=alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:21 ## Governance events - EXECUTIVE_APPOINTED: Jonathan Rubin executive of SUPERNUS PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:executive_appointed:1c0biz1 - EXECUTIVE_APPOINTED: Prat S. Bhatt executive of SUPERNUS PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:executive_appointed:1yto49v - EXECUTIVE_APPOINTED: William Todd Horich executive of SUPERNUS PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:executive_appointed:11woshw - DIRECTOR_APPOINTED: Bethany L. Sensenig seat on SUPERNUS PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:1k4292i - DIRECTOR_APPOINTED: Carrolee Barlow seat on SUPERNUS PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:12agzf9 - DIRECTOR_APPOINTED: Georges Gemayel seat on SUPERNUS PHARMACEUTICALS, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:1czpo6m - DIRECTOR_APPOINTED: Frederick M. Hudson seat on SUPERNUS PHARMACEUTICALS, INC., effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:17un2wn - DIRECTOR_APPOINTED: Jack A. Khattar seat on SUPERNUS PHARMACEUTICALS, INC., effective 2005-01-01. Effective: 2005-01-01. Detected: 2026-10-05T15:31:21.915751+00:00. event_id=alpha:event:director_appointed:1xydjm2 ## Scoped resources - `alpha://company/supernus-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record - `alpha://company/supernus-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/supernus-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/supernus-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=board - `alpha://company/supernus-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/supernus-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/supernus-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/supernus-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/supernus-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/supernus-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/supernus-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/supernus-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/supernus-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/supernus-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/supernus-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/supernus-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/supernus-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/supernus-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/supernus-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/supernus-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=events - `alpha://company/supernus-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/supernus-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/supernus-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Charles W. Newhall, III: Chairman of the Board. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Bethany L. Sensenig: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3. - Carrolee Barlow: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:7. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3. - Carrolee Barlow, M.D., Ph.D.: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Frederick M. Hudson: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:9. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3. - Georges Gemayel: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:10. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3. - Georges Gemayel, Ph.D.: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Jack A. Khattar: Director. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:12. Valid from: 2005-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3. - Frank Mottola: Senior Vice President, Chief Technical Operations Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Jack A. Khattar: President, Chief Executive Officer and Secretary. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Jonathan Rubin: Senior Vice President, Chief Medical Officer, Research and Development. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:15. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b906e9bd5512ae5922857a6f3bc4c5e1781e5ace0d2330182ae86482fcb5a06. - Jonathan Rubin, M.D.: Senior Vice President, Chief Medical Officer, Research and Development. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Padmanabh P. Bhatt, Ph.D.: Senior Vice President of Intellectual Property, Chief Scientific Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - Prat S. Bhatt: Senior Vice President of Intellectual Property, Chief Scientific Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:18. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:35115dcc0f5f5152de9e01e9cc8a8f5fd3a6507409b03a6e1c61bc90a029ad86. - Timothy C. Dec: Senior Vice President, Chief Financial Officer. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. - William Todd Horich: Senior Vice President, Commercial Operations, Marketing, and Market Access. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:20. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a206dbaad43a30166b663513d1a7c6278478c7f8dbf0b8f33be92d4f3e4c225f. - William Todd Horich, Ph.D., MBA: Senior Vice President, Commercial Operations, Marketing, and Market Access. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - SUPERNUS PHARMACEUTICALS, INC.. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9. ## Entity Status - Public listing published. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9. ## Published Fact - US. Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9. ## Security Listing - SUPN (NASDAQ). Claim: alpha:claim:company:2eb0d5fc-bfaf-41de-8ee0-6168096e09e6:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:0ca9cc0f69eac502ab6ed24b040bac5e9b389e1663dd9c5e671ea5529719d1d9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc). - alpha:projection-evidence:document:05bbe9b09b4dfa02c23d865280b427bc444a7c2681d51f29f8b07617bed0f8d8: [SEC DEF 14A 0001104659-26-053111](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm). - alpha:projection-evidence:document:a18a768eaa1243c594663c30ceefa569817aa686151f6cecaea7812c46c619d3: [DEF 14A tm261453-1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm). - alpha:projection-evidence:document:9b906e9bd5512ae5922857a6f3bc4c5e1781e5ace0d2330182ae86482fcb5a06: [SUPN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm). - alpha:projection-evidence:document:35115dcc0f5f5152de9e01e9cc8a8f5fd3a6507409b03a6e1c61bc90a029ad86: [SUPN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm). - alpha:projection-evidence:document:a206dbaad43a30166b663513d1a7c6278478c7f8dbf0b8f33be92d4f3e4c225f: [SUPN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1356576/000110465926053111/tm261453-1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/supernus-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/supernus-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/supernus-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.